Free tool
Stocks above their 200-day average
We cover 16 companies trading above their own 200-day average. The median market value in the group is $842.98M. Across the group, the median move over the past trading day is −0.34%. Price change over the past year runs from −33.2% to +34.9% across the middle 80 percent of the group, with a median of +2.2%.
Other lists in this group
Table
16 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% | Sep 1, 2026 |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% | Sep 1, 2026 |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% | Sep 4, 2026 |
| KMTS | Kestra Medical Technologies, Ltd. | $1.56B | Small cap | +47.61% | Sep 14, 2026 |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +178.79% | Sep 8, 2026 |
| 9627.T | Ain Holdings Inc. | $1.38B | Small cap | +2.85% | Sep 14, 2026 |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% | Sep 9, 2026 |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% | Sep 24, 2026 |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% | Sep 16, 2026 |
| BNTC | Benitec Biopharma Inc. | $442.48M | Small cap | +0.16% | Sep 22, 2026 |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +2.86% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | $240.15M | Small cap | +1.19% | Sep 17, 2026 |
| HITI | High Tide Inc. | $221.43M | Small cap | −30.00% | Sep 14, 2026 |
| ANIX | Anixa Biosciences, Inc. | $122.65M | Small cap | +22.20% | Sep 9, 2026 |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% | Sep 3, 2026 |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% | Sep 23, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.